Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,982 | -2,127 | -10,307 | -7,873 | -5,767 |
| Depreciation Amortization | 83 | 37 | 199 | 151 | 103 |
| Accounts receivable | N/A | N/A | 85 | -307 | N/A |
| Other Working Capital | 1,307 | 637 | 1,792 | 289 | -510 |
| Other Operating Activity | 2,377 | 133 | 1,256 | 1,505 | 1,041 |
| Operating Cash Flow | $-2,215 | $-1,320 | $-6,975 | $-6,235 | $-5,133 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $0 | $N/A | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 155 | 280 | 582 | -199 | -199 |
| Debt Issued | N/A | N/A | 450 | 450 | 450 |
| Common Stock Issued | 1,993 | 970 | 5,848 | 5,849 | 5,536 |
| Financing Cash Flow | $2,148 | $1,250 | $6,880 | $6,100 | $5,787 |
| Beginning Cash Position | 276 | 276 | 371 | 371 | 371 |
| End Cash Position | 209 | 206 | 276 | 236 | 1,025 |
| Net Cash Flow | $-67 | $-70 | $-95 | $-135 | $654 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,215 | -1,320 | -6,975 | -6,235 | -5,133 |
| Free Cash Flow | -2,215 | -1,320 | -6,975 | -6,235 | -5,133 |